Chemoinformaics analysis of 1,6-DIACETOXYHEXANE
| Molecular Weight | 202.25 | nRot | 7 |
| Heavy Atom Molecular Weight | 184.106 | nRig | 2 |
| Exact Molecular Weight | 202.121 | nRing | 0 |
| Solubility: LogS | -1.577 | nHRing | 0 |
| Solubility: LogP | 1.776 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 31.9103 |
| nHD | 0 | BPOL | 23.2657 |
| QED | 0.465 |
| Synth | 1.88 |
| Natural Product Likeliness | 0.443 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.149 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.581 |
| MDCK | 0.0000389 |
| BBB | 0.969 |
| PPB | 0.39859 |
| VDSS | 0.885 |
| FU | 0.738805 |
| CYP1A2-inh | 0.949 |
| CYP1A2-sub | 0.108 |
| CYP2c19-inh | 0.515 |
| CYP2c19-sub | 0.168 |
| CYP2c9-inh | 0.094 |
| CYP2c9-sub | 0.091 |
| CYP2d6-inh | 0.063 |
| CYP2d6-sub | 0.113 |
| CYP3a4-inh | 0.043 |
| CYP3a4-sub | 0.254 |
| CL | 4.221 |
| T12 | 0.74 |
| hERG | 0.054 |
| Ames | 0.01 |
| ROA | 0.009 |
| SkinSen | 0.878 |
| Carcinogencity | 0.173 |
| EI | 0.985 |
| Respiratory | 0.06 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.874425 |